Beni B. Wolf
Beni B. Wolf publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Lung Cancer Treatments and Mutations, Cell death mechanisms and regulation and Fibroblast Growth Factor Research.
- World rank
- #176,874 of 7,710,434 ranked researchers
- Rank in United States
- #66,091 of 1,627,098
- Works
- 243
- Citations
- 11k
- Citations per work
- 44.4
What does Beni B. Wolf research?
Beni B. Wolf's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (30%), Neuroscience (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences8936.6%
- Everything else8032.9%
- Health Sciences7430.5%
- Medicine7430.5%
- 1Molecular Biology25% of their works
- 2Pulmonary and Respiratory Medicine13% of their works
- 3Oncology13% of their works
- 4Cancer Research8% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
Which keywords describe Beni B. Wolf's research?
The keywords of their largest research topics: Targeted Therapy, Cancer Therapy, ALK Inhibitors, EGFR Mutations, Angiogenesis, Apoptosis, Cell Death and FGF21.
- Neuropeptides
- HER2
- Breast Cancer
- Matrix Metalloproteinases
- Fibroblast Activation Protein
- FGF21
- Apoptosis
- EGFR Mutations
- Cancer Therapy
- Targeted Therapy
- ALK Inhibitors
- Angiogenesis
- Cell Death
- Fibroblast Growth Factor
- Tumor Microenvironment
- Tissue Inhibitors of Metalloproteinases
- Cancer Genomics
- Mutational Signatures
- Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Targeted Therapy212 topics
- Cancer Therapy192 topics
- ALK Inhibitors161 topic
- EGFR Mutations161 topic
- Angiogenesis132 topics
- Apoptosis121 topic
- Cell Death121 topic
- FGF2191 topic
- Fibroblast Growth Factor91 topic
- Fibroblast Activation Protein71 topic
- Tumor Microenvironment71 topic
- Matrix Metalloproteinases61 topic
- Tissue Inhibitors of Metalloproteinases61 topic
- Breast Cancer51 topic
- Cancer Genomics51 topic
- HER251 topic
- Mutational Signatures51 topic
- Neuropeptides51 topic
- Receptors51 topic
Where does Beni B. Wolf work?
Beni B. Wolf's main affiliation in the publication record is Blueprint Medicines (United States), United States.
How many publications and citations does Beni B. Wolf have?
OpenAlex counts 243 works and 10,781 citations for Beni B. Wolf, an h-index of 33, ranking #176,874 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Beni B. Wolf. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.